Merck pours $400M into flea drugs for Fido

Merck has found its newest $400 million, just don’t expect to ever personally receive a drug from it. The NJ-based pharma giant has acquired Sentinel, a maker of drugs that protect dogs and other companion animals from ticks, fleas and other parasites.